Ligne de temps

Rita Azevedo
Ingénieur(e) de Recherche
09 avr. 2022
publication

Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications.

Lire plus
01 janv. 2022
publication

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.

Lire plus
09 juin 2021
publication

Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.

Lire plus
07 févr. 2021
publication

Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.

Lire plus
02 avr. 2020
publication

Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells.

Lire plus
25 mars 2019
publication

Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.

Lire plus
01 janv. 2019
publication

Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.

Lire plus
01 juil. 2018
publication

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.

Lire plus
01 mai 2018
publication

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

Lire plus
16 janv. 2018
publication

In silico approaches for unveiling novel glycobiomarkers in cancer.

Lire plus
01 janv. 2018
publication

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.

Lire plus
01 déc. 2017
publication

Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.

Lire plus
31 oct. 2017
publication

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Lire plus
01 août 2017
publication

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.

Lire plus
01 oct. 2016
publication

Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.

Lire plus
27 sept. 2016
publication

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.

Lire plus
01 oct. 2015
publication

Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs.

Lire plus
28 sept. 2015
publication

Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.

Lire plus
16 juin 2015
publication

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?

Lire plus
01 mars 2015
publication

Future perspectives of Smartphone applications for rheumatic diseases self-management.

Lire plus
01 nov. 2014
publication

SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.

Lire plus
01 avr. 2014
publication

SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.

Lire plus
01 janv. 2014
publication

Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.

Lire plus
01 janv. 2014
publication

Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.

Lire plus
01 janv. 2014
publication

Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.

Lire plus
01 août 2013
publication

Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics.

Lire plus